[1]
|
Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
|
[2]
|
侯清涛, 李芸, 李舍予, 等. 全球糖尿病疾病负担现状[J]. 中国糖尿病杂志, 2016, 24(1): 92-96.
|
[3]
|
Flyvbjerg, A. (2017) The Role of the Complement System in Diabetic Nephropathy. Nature Reviews Nephrology, 13, 311-318. https://doi.org/10.1038/nrneph.2017.31
|
[4]
|
赵文倩, 王艳军. 补体系统与糖尿病微血管病变关系的研究进展[J]. 中国医师杂志, 2019, 21(6): 947-950.
|
[5]
|
Xu, H. and Chen, M. (2017) Diabetic Retinopathy and Dysregulated Innate Immunity. Vision Research, 139, 39-46.
https://doi.org/10.1016/j.visres.2017.04.013
|
[6]
|
Ajjan, R. and Schroeder, V. (2019) Role of Complement in Diabetes. Molecular Immunology, 114, 270-277.
https://doi.org/10.1016/j.molimm.2019.07.031
|
[7]
|
Donath, M. (2014) Targeting Inflammation in the Treatment of Type 2 Diabetes: Time to Start. Nature Reviews Drug Discovery, 13, 465-476. https://doi.org/10.1038/nrd4275
|
[8]
|
Phieler, J., Garcia-Martin, R., Lambris, J., et al. (2013) The Role of the Complement System in Metabolic Organs and Metabolic Diseases. Seminars in Immunology, 25, 47-53. https://doi.org/10.1016/j.smim.2013.04.003
|
[9]
|
Bus, P., Chua, J., Klessens, C., et al. (2018) Complement Activation in Patients with Diabetic Nephropathy. Kidney International Reports, 3, 302-313. https://doi.org/10.1016/j.ekir.2017.10.005
|
[10]
|
Woroniecka, K., Park, A., Mohtat, D., et al. (2011) Transcriptome Analysis of Human Diabetic Kidney Disease. Diabetes, 60, 2354-2369. https://doi.org/10.2337/db10-1181
|
[11]
|
Østergaard, J., Thiel, S., Gadjeva, M., et al. (2007) Mannose-Binding Lectin Deficiency Attenuates Renal Changes in a Streptozotocin-Induced model of Type 1 Diabetes in Mice. Diabetologia, 50, 1541-1549.
https://doi.org/10.1007/s00125-007-0686-0
|
[12]
|
Ostergaard, J., Bjerre, M., Dagnaes-Hansen, F., et al. (2013) Diabetes-Induced Changes in Mannan-Binding Lectin Levels and Complement Activation in a Mouse Model of Type 1 Diabetes. Scandinavian Journal of Immunology, 77, 187-194. https://doi.org/10.1111/sji.12027
|
[13]
|
Axelgaard, E., Østergaard, J., Thiel, S., et al. (2017) Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin. Journal of Diabetes Research, 2017, Article ID: 6368780. https://doi.org/10.1155/2017/6368780
|
[14]
|
Hansen, T., Forsblom, C., Saraheimo, M., et al. (2010) Association between Mannose-Binding Lectin, High-Sensitivity C-Reactive Protein and the Progression of Diabetic Nephropathy in Type 1 Diabetes. Diabetologia, 53, 1517-1524.
https://doi.org/10.1007/s00125-010-1742-8
|
[15]
|
Zheng, J., Ren, X., Jiang, Z., et al. (2018) Lectin-Induced Renal Local Complement Activation Is Involved in Tubular Interstitial Injury in Diabetic Nephropathy. Clinica Chimica Acta, 482, 65-73.
https://doi.org/10.1016/j.cca.2018.03.033
|
[16]
|
Li, X., Chang, D., Chen, M., et al. (2019) Complement Activation in Patients with Diabetic Nephropathy. Diabetes & Metabolism, 45, 248-253. https://doi.org/10.1016/j.diabet.2018.04.001
|
[17]
|
Li, L., Yin, Q., Tang, X., et al. (2014) C3a Receptor Antagonist Ameliorates Inflammatory and Fibrotic Signals in Type 2 Diabetic Nephropathy by Suppressing the Activation of TGF-β/smad3 and IKBα Pathway. PLoS ONE, 9, e113639. https://doi.org/10.1371/journal.pone.0113639
|
[18]
|
Ghosh, P., Sahoo, R., Vaidya, A., et al. (2015) Role of Complement and Complement Regulatory Proteins in the Complications of Diabetes. Endocrine Reviews, 36, 272-288. https://doi.org/10.1210/er.2014-1099
|
[19]
|
Penning, M., Chua, J., Van Kooten, C., et al. (2015) Classical Complement Pathway Activation in the Kidneys of Women with Preeclampsia. Hypertension, 66, 117-125. https://doi.org/10.1161/HYPERTENSIONAHA.115.05484
|
[20]
|
Muramatsu, D., Wakabayashi, Y., Usui, Y., et al. (2013) Correlation of Complement Fragment C5a with Inflammatory Cytokines in the Vitreous of Patients with Proliferative Diabetic Retinopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology, 251, 15-17. https://doi.org/10.1007/s00417-012-2024-6
|
[21]
|
Wang, H., Feng, L., Hu, J., et al. (2013) Differentiating Vitreous Proteomes in Proliferative Diabetic Retinopathy Using High-Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry. Experimental Eye Research, 108, 110-119. https://doi.org/10.1016/j.exer.2012.11.023
|
[22]
|
Geng, P., Ding, Y., Qiu, L., et al. (2015) Serum Mannose-Binding Lectin Is a Strong Biomarker of Diabetic Retinopathy in Chinese Patients with Diabetes. Diabetes Care, 38, 868-875. https://doi.org/10.2337/dc14-1873
|
[23]
|
Zhang, L., Li, Y., Payne, J., et al. (2016) Presence of Retinal Pericyte-Reactive Autoantibodies in Diabetic Retinopathy Patients. Scientific Reports, 6, Article No. 20341. https://doi.org/10.1038/srep20341
|
[24]
|
Huang, C., Fisher, K., Hammer, S., et al. (2018) Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway. Diabetes, 67, 1639-1649.
https://doi.org/10.2337/db17-1587
|
[25]
|
Cheng, L., Bu, H., Portillo, J., et al. (2013) Modulation of Retinal Müller Cells by Complement Receptor C5aR. Investigative Ophthalmology & Visual Science, 54, 8191-8198. https://doi.org/10.1167/iovs.13-12428
|
[26]
|
廖怿. 补体功能失调对糖尿病视网膜病变的影响[J]. 中华实验眼科杂志, 2020, 38(1): 68-72.
|
[27]
|
李勇, 齐丽翠, 张然, 等. 血清成纤维细胞生长因子21水平与糖尿病周围神经病变的相关性研究[J]. 中国全科医学, 2021, 24(33): 4229-4233.
|
[28]
|
Kim, S., Won, J., Kwon, H., et al. (2014) Prevalence and Clinical Implications of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes: Results from a Nationwide Hospital-Based Study of Diabetic Neuropathy in Korea. Diabetes Research and Clinical Practice, 103, 522-529. https://doi.org/10.1016/j.diabres.2013.12.003
|
[29]
|
Lu, Y., Li, R., Zhu, J., et al. (2019) Fibroblast Growth Factor 21 Facilitates Peripheral Nerve Regeneration through Suppressing Oxidative Damage and Autophagic Cell Death. Journal of Cellular and Molecular Medicine, 23, 497-511.
https://doi.org/10.1111/jcmm.13952
|
[30]
|
Collins, M., Periquet-Collins, I., Sahenk, Z., et al. (2010) Direct Immunofluoresence in Vasculitic Neuropathy: Specificity of Vascular Immune Deposits. Muscle Nerve, 42, 62-69. https://doi.org/10.1002/mus.21639
|
[31]
|
Rosoklija, G., Dwork, A., Younger, D., et al. (2000) Local Activation of the Complement System in Endoneurial Microvessels of Diabetic Neuropathy. Acta Neuropathologica, 99, 55-62. https://doi.org/10.1007/PL00007406
|
[32]
|
Nie, F., Su, D., Shi, Y., et al. (2015) A Preliminary Study on the Role of the Complement Regulatory Protein, Cluster of Differentiation 55, in Mice with Diabetic Neuropathic Pain. Molecular Medicine Reports, 11, 2076-2082.
https://doi.org/10.3892/mmr.2014.2896
|